 |
인쇄하기
취소
|
Pharmaceutical firms developing lipid-lowering medicines
Korean pharmaceutical firms are preparing to challenge AstraZeneca’s grip on the lipid-lowering medicine market with generics of rosuvastatin, according to the Korea Food and Drug Administration.
According to the drug authorities, 29 local drug makers, which have thrown their hat into the ring, will conduct bioequivalence testing from the second half of this year.
The local pharmaceutica...
According to the drug authorities, 29 local drug makers, which have thrown their hat into the ring, will conduct bioequivalence testing from the second half of this year.
The local pharmaceutica...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.